Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dagmar Pich

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genomeMarkus Kalla, Anne Schmeinck, Martin Bergbauer, et al.
Nucleic Acids Research|June 21, 2008
Conditional gene vectors regulated in cisDagmar Pich, Sibille Humme, Mark-Peter Spindler, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 2006
Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genesMarkus Altmann, Dagmar Pich, Romana Ruiss, et al.
Vaccines|March 30, 2023
Assessing the Efficacy of VLP-Based Vaccine against Epstein-Barr Virus Using a Rabbit ModelNarendran Reguraman, Asma Hassani, Pretty S Philip, et al.
Journal of Virology|September 5, 2002
Epstein-Barr virus mRNA export factor EB2 is essential for production of infectious virusHenri Gruffat, Julien Batisse, Dagmar Pich, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2019
Epstein-Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infectionPaulina Mrozek-Gorska, Alexander Buschle, Dagmar Pich, et al.
Plos Pathogens|April 15, 2021
Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infectionEzgi Akidil, Manuel Albanese, Alexander Buschle, et al.
Biomedicines|November 25, 2023
SARS-CoV-2 and Epstein-Barr Virus-like Particles Associate and Fuse with Extracellular Vesicles in Virus Neutralization TestsJohannes Roessler, Dagmar Pich, Verena Krähling, et al.
Journal of Virology|May 30, 2025
Assessing the fitness of Epstein-Barr virus following its reactivationYen-Fu Adam Chen, Bianca Mocanu, Ezgi Akidil, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 2008
Interaction between HMGA1a and the origin recognition complex creates site-specific replication originsAndreas W Thomae, Dagmar Pich, Jan Brocher, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genomeMarkus Kalla, Anne Schmeinck, Martin Bergbauer, et al.
Nucleic Acids Research|June 21, 2008
Conditional gene vectors regulated in cisDagmar Pich, Sibille Humme, Mark-Peter Spindler, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 2006
Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genesMarkus Altmann, Dagmar Pich, Romana Ruiss, et al.
Vaccines|March 30, 2023
Assessing the Efficacy of VLP-Based Vaccine against Epstein-Barr Virus Using a Rabbit ModelNarendran Reguraman, Asma Hassani, Pretty S Philip, et al.
Journal of Virology|September 5, 2002
Epstein-Barr virus mRNA export factor EB2 is essential for production of infectious virusHenri Gruffat, Julien Batisse, Dagmar Pich, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2019
Epstein-Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infectionPaulina Mrozek-Gorska, Alexander Buschle, Dagmar Pich, et al.
Plos Pathogens|April 15, 2021
Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infectionEzgi Akidil, Manuel Albanese, Alexander Buschle, et al.
Biomedicines|November 25, 2023
SARS-CoV-2 and Epstein-Barr Virus-like Particles Associate and Fuse with Extracellular Vesicles in Virus Neutralization TestsJohannes Roessler, Dagmar Pich, Verena Krähling, et al.
Journal of Virology|May 30, 2025
Assessing the fitness of Epstein-Barr virus following its reactivationYen-Fu Adam Chen, Bianca Mocanu, Ezgi Akidil, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 2008
Interaction between HMGA1a and the origin recognition complex creates site-specific replication originsAndreas W Thomae, Dagmar Pich, Jan Brocher, et al.
Pageof 2